SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Dexcom on Monday announced its new over-the-counter continuous glucose monitor Stelo is officially available for purchase in the U.S. Glucose is a type of sugar people receive from food, and it's the ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
Dexcom’s Stelo glucose biosensor is promoted as a continuous monitor that helps track glucose in the body. What separates it from other continuous glucose monitoring (CGM) systems — special monitors ...
DexCom Inc. DXCM recently announced the FDA clearance of its Stelo glucose biosensor, available over-the-counter to consumers without a prescription. The company’s latest Continuous Glucose Monitoring ...